These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2413558)

  • 1. [Treatment of obstructive symptomatology caused by prostatic adenoma with an extract of Serenoa repens. Double-blind clinical study vs. placebo].
    Tasca A; Barulli M; Cavazzana A; Zattoni F; Artibani W; Pagano F
    Minerva Urol Nefrol; 1985; 37(1):87-91. PubMed ID: 2413558
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
    Champault G; Patel JC; Bonnard AM
    Br J Clin Pharmacol; 1984 Sep; 18(3):461-2. PubMed ID: 6207850
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
    Grasso M; Montesano A; Buonaguidi A; Castelli M; Lania C; Rigatti P; Rocco F; Cesana BM; Borghi C
    Arch Esp Urol; 1995; 48(1):97-103. PubMed ID: 7537488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma].
    Vinarov AZ; Aliaev IuG; Lokshin KL
    Urologiia; 2009; (1):84, 86-7. PubMed ID: 19432240
    [No Abstract]   [Full Text] [Related]  

  • 5. [Saw palmetto fruit extract for treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Bauer HW; Casarosa C; Cosci M; Fratta M; Blessmann G
    MMW Fortschr Med; 1999 Jun; 141(25):62. PubMed ID: 10897913
    [No Abstract]   [Full Text] [Related]  

  • 6. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical treatment of prostatic adenoma. Controlled trial: PA 109 vs placebo in 110 patients].
    Champault G; Bonnard AM; Cauquil J; Patel JC
    Ann Urol (Paris); 1984 Dec; 18(6):407-10. PubMed ID: 6085231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant extracts in BPH.
    Di Silverio F; Flammia GP; Sciarra A; Caponera M; Mauro M; Buscarini M; Tavani M; D'Eramo G
    Minerva Urol Nefrol; 1993 Dec; 45(4):143-9. PubMed ID: 7517582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial].
    Glemain P; Coulange C; Billebaud T; Gattegno B; Muszynski R; Loeb G;
    Prog Urol; 2002 Jun; 12(3):395-403; discussion 404. PubMed ID: 12189745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of permixon in benign prostatic hypertrophy.
    Reece Smith H; Memon A; Smart CJ; Dewbury K
    Br J Urol; 1986 Feb; 58(1):36-40. PubMed ID: 2418902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens (Sabal fructus)].
    Schilcher H
    Wien Med Wochenschr; 1999; 149(8-10):236-40. PubMed ID: 10483690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined extract of Sabal palm and nettle in the treatment of patients with lower urinary tract symptoms in double blind, placebo-controlled trial].
    Lopatkin NA; Sivkov AV; Medvedev AA; Walter K; Schlefke S; Avdeĭchuk IuI; Golubev GV; Mel'nik KP; Elenberger NA; Engelman U
    Urologiia; 2006; (2):12, 14-9. PubMed ID: 16708583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of the lipidosterolic extract of Serenoa repens (Permixon) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens.
    Stepanov VN; Siniakova LA; Sarrazin B; Raynaud JP
    Adv Ther; 1999; 16(5):231-41. PubMed ID: 10915398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.
    Boyle P; Robertson C; Lowe F; Roehrborn C
    BJU Int; 2004 Apr; 93(6):751-6. PubMed ID: 15049985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gerber GS; Fitzpatrick JM
    BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extracts Serenoa repens in the treatment of prostatic adenoma and chronic abacterial prostatitis: results of short-term (3-month courses) therapy].
    Aliaev IuG; Vinarov AZ; Lokshin KL; Spivak LG
    Urologiia; 2007; (2):80-2. PubMed ID: 17578203
    [No Abstract]   [Full Text] [Related]  

  • 17. [Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and serenoa repens].
    Adriazola Semino M; Lozano Ortega JL; García Cobo E; Tejeda Báñez E; Romero Rodríguez F
    Arch Esp Urol; 1992 Apr; 45(3):211-3. PubMed ID: 1384438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone.
    Casarosa C; Cosci di Coscio M; Fratta M
    Clin Ther; 1988; 10(5):585-8. PubMed ID: 2485240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serenoa repens (Saw Palmetto).
    Donato A
    J Soc Integr Oncol; 2008; 6(1):41-2. PubMed ID: 18302910
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of the prostatism syndrome. Comparative study].
    Martínez Agulló E; Gallego Gómez J; Jiménez Cruz FJ
    Arch Esp Urol; 1987 May; 40(4):247-53. PubMed ID: 2443084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.